INmune Bio SG&A Expense (Quarterly) Trends

INmune Bio Inc (INMB)

9.46 -0.08 (-0.79%) USD | NASDAQ | May 31, 16:00

9.475 +0.02 (+0.16%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	2.338M
December 31, 2023	2.40M
September 30, 2023	2.586M
June 30, 2023	2.309M
March 31, 2023	2.328M
December 31, 2022	2.329M
September 30, 2022	2.382M
June 30, 2022	2.215M
March 31, 2022	2.332M
December 31, 2021	2.125M
September 30, 2021	2.515M
June 30, 2021	2.09M
March 31, 2021	2.061M
December 31, 2020	1.361M

Date	Value
September 30, 2020	2.457M
June 30, 2020	1.204M
March 31, 2020	1.299M
December 31, 2019	1.466M
September 30, 2019	1.916M
June 30, 2019	1.336M
March 31, 2019	1.298M
December 31, 2018	0.8877M
September 30, 2018	0.8852M
June 30, 2018	5.886M
March 31, 2018	2.742M
December 31, 2017	0.1599M
September 30, 2017	0.2612M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.204M

Minimum

Jun 2020

2.586M

Maximum

Sep 2023

2.052M

Average

2.262M

Median

SG&A Expense (Quarterly) Benchmarks